394 related articles for article (PubMed ID: 35787460)
1. Fabrication of bilayer tablets using hot melt extrusion-based dual-nozzle fused deposition modeling 3D printing.
Zhang P; Xu P; Chung S; Bandari S; Repka MA
Int J Pharm; 2022 Aug; 624():121972. PubMed ID: 35787460
[TBL] [Abstract][Full Text] [Related]
2. Development of multiple structured extended release tablets via hot melt extrusion and dual-nozzle fused deposition modeling 3D printing.
Zhang P; Li J; Ashour EA; Chung S; Wang H; Vemula SK; Repka MA
Int J Pharm; 2024 Mar; 653():123905. PubMed ID: 38355075
[TBL] [Abstract][Full Text] [Related]
3. Fabrication of timed-release indomethacin core-shell tablets for chronotherapeutic drug delivery using dual nozzle fused deposition modeling (FDM) 3D printing.
Chung S; Zhang P; Repka MA
Eur J Pharm Biopharm; 2023 Jul; 188():254-264. PubMed ID: 37201727
[TBL] [Abstract][Full Text] [Related]
4. 3D printing of pharmaceutical oral solid dosage forms by fused deposition: The enhancement of printability using plasticised HPMCAS.
Oladeji S; Mohylyuk V; Jones DS; Andrews GP
Int J Pharm; 2022 Mar; 616():121553. PubMed ID: 35131354
[TBL] [Abstract][Full Text] [Related]
5. Impact of drug load and polymer molecular weight on the 3D microstructure of printed tablets.
Larsen BS; Kissi E; Nogueira LP; Genina N; Tho I
Eur J Pharm Sci; 2024 Jan; 192():106619. PubMed ID: 37866675
[TBL] [Abstract][Full Text] [Related]
6. Coupling 3D printing with hot-melt extrusion to produce controlled-release tablets.
Zhang J; Feng X; Patil H; Tiwari RV; Repka MA
Int J Pharm; 2017 Mar; 519(1-2):186-197. PubMed ID: 28017768
[TBL] [Abstract][Full Text] [Related]
7. Fabrication of Taste-Masked Donut-Shaped Tablets Via Fused Filament Fabrication 3D Printing Paired with Hot-Melt Extrusion Techniques.
Wang H; Dumpa N; Bandari S; Durig T; Repka MA
AAPS PharmSciTech; 2020 Aug; 21(7):243. PubMed ID: 32856144
[TBL] [Abstract][Full Text] [Related]
8. A Lower Temperature FDM 3D Printing for the Manufacture of Patient-Specific Immediate Release Tablets.
Okwuosa TC; Stefaniak D; Arafat B; Isreb A; Wan KW; Alhnan MA
Pharm Res; 2016 Nov; 33(11):2704-12. PubMed ID: 27506424
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of high melting point hydrochlorothiazide processing via cocrystal formation by hot melt extrusion paired fused filament fabrication as a 3D-printed cocrystal tablet.
Nyavanandi D; Mandati P; Narala S; Alzahrani A; Kolimi P; Pradhan A; Bandari S; Repka MA
Int J Pharm; 2022 Nov; 628():122283. PubMed ID: 36244563
[TBL] [Abstract][Full Text] [Related]
10. Formulation of 3D Printed Tablet for Rapid Drug Release by Fused Deposition Modeling: Screening Polymers for Drug Release, Drug-Polymer Miscibility and Printability.
Solanki NG; Tahsin M; Shah AV; Serajuddin ATM
J Pharm Sci; 2018 Jan; 107(1):390-401. PubMed ID: 29066279
[TBL] [Abstract][Full Text] [Related]
11. Hydroxypropyl methylcellulose-based controlled release dosage by melt extrusion and 3D printing: Structure and drug release correlation.
Zhang J; Yang W; Vo AQ; Feng X; Ye X; Kim DW; Repka MA
Carbohydr Polym; 2017 Dec; 177():49-57. PubMed ID: 28962795
[TBL] [Abstract][Full Text] [Related]
12. 3D printing of immediate-release tablets containing olanzapine by filaments extrusion.
Bhatt U; Malakar TK; Murty US; Banerjee S
Drug Dev Ind Pharm; 2021 Aug; 47(8):1200-1208. PubMed ID: 33493008
[TBL] [Abstract][Full Text] [Related]
13. Preparation and characterization of hot-melt extruded polycaprolactone-based filaments intended for 3D-printing of tablets.
Viidik L; Vesala J; Laitinen R; Korhonen O; Ketolainen J; Aruväli J; Kirsimäe K; Kogermann K; Heinämäki J; Laidmäe I; Ervasti T
Eur J Pharm Sci; 2021 Mar; 158():105619. PubMed ID: 33115676
[TBL] [Abstract][Full Text] [Related]
14. Amorphous solid dispersion of a binary formulation with felodipine and HPMC for 3D printed floating tablets.
Mora-Castaño G; Millán-Jiménez M; Niederquell A; Schönenberger M; Shojaie F; Kuentz M; Caraballo I
Int J Pharm; 2024 Jun; 658():124215. PubMed ID: 38740104
[TBL] [Abstract][Full Text] [Related]
15. Development of multifunctional drug delivery system via hot-melt extrusion paired with fused deposition modeling 3D printing techniques.
Zhang Z; Feng S; Almotairy A; Bandari S; Repka MA
Eur J Pharm Biopharm; 2023 Feb; 183():102-111. PubMed ID: 36632906
[TBL] [Abstract][Full Text] [Related]
16. Coupling hot melt extrusion and fused deposition modeling: Critical properties for successful performance.
Bandari S; Nyavanandi D; Dumpa N; Repka MA
Adv Drug Deliv Rev; 2021 May; 172():52-63. PubMed ID: 33571550
[TBL] [Abstract][Full Text] [Related]
17. Role of release modifiers to modulate drug release from fused deposition modelling (FDM) 3D printed tablets.
Shi K; Salvage JP; Maniruzzaman M; Nokhodchi A
Int J Pharm; 2021 Mar; 597():120315. PubMed ID: 33540000
[TBL] [Abstract][Full Text] [Related]
18. Hot Melt Extrusion and its Application in 3D Printing of Pharmaceuticals.
Deshkar S; Rathi M; Zambad S; Gandhi K
Curr Drug Deliv; 2021; 18(4):387-407. PubMed ID: 33176646
[TBL] [Abstract][Full Text] [Related]
19. Performance and paroxetine stability in tablets manufactured by fused deposition modelling-based 3D printing.
Figueiredo S; Fernandes AI; Carvalho FG; Pinto JF
J Pharm Pharmacol; 2022 Jan; 74(1):67-76. PubMed ID: 34591102
[TBL] [Abstract][Full Text] [Related]
20. 3D Printed Intragastric Floating and Sustained-Release Tablets with Air Chambers.
Zhao X; Wei W; Niu R; Li Q; Hu C; Jiang S
J Pharm Sci; 2022 Jan; 111(1):116-123. PubMed ID: 34303671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
